ZCCHC17, also known as zinc finger CCHC-type containing 17, is a protein encoded by the ZCCHC17 gene in humans. This protein is implicated in the intricate network of RNA metabolism, playing a role in the processing and functioning of RNA within the cell. As a part of the cellular machinery, ZCCHC17 is involved in the regulation of various aspects of RNA biology, including RNA splicing, export, and stability. The precise regulation of ZCCHC17 expression is crucial for maintaining cellular homeostasis and responding to a myriad of intracellular and extracellular signals. Understanding the molecular mechanisms underlying the expression of ZCCHC17 can provide insight into the complex orchestration of gene expression and the maintenance of RNA integrity within the cell.
The expression of ZCCHC17 can be influenced by a diverse array of chemical compounds that act as activators, each engaging with cellular mechanisms to promote the upregulation of this protein. For instance, retinoic acid, known for its role in cell differentiation and proliferation, could t enhance ZCCHC17 expression through retinoic acid receptors, which may bind to specific response elements on the gene's promoter. Likewise, forskolin, by elevating cAMP levels, might activate a signaling cascade that influences CREB, a transcription factor that could lead to increased transcription of ZCCHC17. Compounds such as trichostatin A and sodium butyrate offer another avenue for upregulation by modifying chromatin structure, thereby making the ZCCHC17 gene more accessible for transcription. This is accomplished via the inhibition of histone deacetylases, which allows for a looser, transcriptionally active chromatin state. Moreover, agents like 5-azacytidine could upregulate ZCCHC17 expression by reducing DNA methylation at the gene promoter, thereby diminishing gene silencing.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid might activate retinoic acid receptors, which could upregulate ZCCHC17 by binding to retinoic acid response elements in its promoter region. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could raise cAMP, potentially stimulating a signaling cascade that leads to the activation of CREB and subsequent upregulation of ZCCHC17 transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may prevent histone deacetylation, possibly resulting in a more accessible chromatin structure at the ZCCHC17 locus and enhanced transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could inhibit HDACs, possibly leading to increased acetylation at the ZCCHC17 promoter and an upsurge in its gene expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol may bind estrogen receptors that interact with estrogen response elements on the ZCCHC17 promoter, stimulating its transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could engage glucocorticoid receptors, which might bind to glucocorticoid response elements upstream of ZCCHC17, enhancing its expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA could activate protein kinase C, which may influence signaling pathways leading to the upregulation of ZCCHC17 expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium might inhibit GSK-3, potentially stabilizing transcription factors that enhance the transcription of ZCCHC17. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Hydrocortisone may activate glucocorticoid receptors, potentially resulting in an increase in ZCCHC17 expression through receptor-mediated transcriptional activation. | ||||||